HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hetty Timmer-Bosscha Selected Research
Hetty Timmer-Bosscha Research Topics
Disease
23
Neoplasms (Cancer)
01/2022 - 09/2008
9
Breast Neoplasms (Breast Cancer)
09/2020 - 06/2005
5
Ovarian Neoplasms (Ovarian Cancer)
09/2015 - 05/2010
5
Neoplasm Metastasis (Metastasis)
01/2015 - 04/2009
4
Chronic Obstructive Pulmonary Disease (COPD)
01/2008 - 06/2005
3
Residual Neoplasm
09/2020 - 08/2012
2
Ovarian Epithelial Carcinoma
09/2015 - 11/2012
2
Prostatic Neoplasms (Prostate Cancer)
10/2014 - 08/2012
2
Carcinoma (Carcinomatosis)
08/2012 - 04/2009
1
Male Breast Neoplasms (Male Breast Cancer)
01/2020
1
Hemangioblastoma
10/2016
1
Colonic Neoplasms (Colon Cancer)
03/2016
1
Polyps
03/2016
1
Adenoma (Adenomas)
03/2016
1
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
03/2016
1
Pathologic Complete Response
01/2015
1
Rectal Neoplasms (Rectal Cancer)
01/2015
1
Triple Negative Breast Neoplasms
09/2014
1
Esophageal Neoplasms (Esophageal Cancer)
06/2013
1
Carcinogenesis
11/2012
1
Leukemia
08/2012
1
Embryonal Carcinoma
10/2010
1
Testicular Neoplasms (Testicular Cancer)
10/2010
1
Infections
04/2009
1
Lymphoma (Lymphomas)
04/2009
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2009
Drug/Important Bio-Agent (IBA)
10
Proteins (Proteins, Gene)
FDA Link
10/2016 - 06/2005
7
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2016 - 05/2010
4
Biomarkers (Surrogate Marker)
IBA
07/2014 - 02/2010
4
89Zr-bevacizumab
IBA
07/2013 - 05/2010
4
multidrug resistance-associated protein 1
IBA
01/2008 - 06/2005
3
Transforming Growth Factors (Transforming Growth Factor)
IBA
09/2015 - 12/2011
3
Bevacizumab (Avastin)
FDA Link
01/2015 - 01/2012
3
Chemokines
IBA
01/2015 - 07/2007
3
Pharmaceutical Preparations
IBA
06/2013 - 12/2011
3
Smoke
IBA
01/2008 - 01/2007
2
Androgen Receptors (Androgen Receptor)
IBA
11/2018 - 09/2015
2
Carboplatin (JM8)
FDA Link
Generic
09/2015 - 11/2012
2
Chemokine Receptors
IBA
01/2015 - 04/2009
2
plerixafor
FDA Link
10/2014 - 08/2012
2
Immunosorbents
IBA
07/2013 - 05/2010
2
Enzymes
IBA
07/2013 - 05/2010
2
Cisplatin (Platino)
FDA Link
Generic
10/2010 - 05/2010
1
Collagen
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
01/2022
1
Cathepsins
IBA
09/2020
1
Cysteine (L-Cysteine)
FDA Link
09/2020
1
CXC Chemokines
IBA
01/2020
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
01/2020
1
ErbB Receptors (EGF Receptor)
IBA
11/2018
1
human ERBB2 protein
IBA
11/2018
1
Trastuzumab (Herceptin)
FDA Link
11/2018
1
DNA (Deoxyribonucleic Acid)
IBA
10/2016
1
Sodium Chloride
FDA Link
Generic
03/2016
1
Zoledronic Acid (Zometa)
FDA Link
09/2015
1
Diphosphonates (Bisphosphonates)
IBA
09/2015
1
Estrogen Receptors
IBA
09/2015
1
Hormones (Hormone)
IBA
09/2015
1
Progesterone Receptors (Progesterone Receptor)
IBA
09/2015
1
Capecitabine (Xeloda)
FDA Link
01/2015
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2015
1
Ligands
IBA
01/2015
1
Paraffin
IBA
01/2015
1
N 30
IBA
01/2015
1
Luciferases
IBA
10/2014
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
09/2014
1
Insulin-Like Peptides
IBA
09/2014
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
07/2014
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2013
1
TB-403
IBA
06/2013
1
zirconium-89-trastuzumab
IBA
06/2013
1
Monoclonal Antibodies
IBA
06/2013
1
Everolimus
FDA Link
11/2012
1
MTOR Inhibitors
IBA
11/2012
1
tanespimycin (17AAG)
IBA
11/2012
1
Lapatinib (GW572016)
FDA Link
11/2012
1
Angiogenesis Inhibitors
IBA
11/2012
1
Paclitaxel (Taxol)
FDA Link
Generic
11/2012
1
Docetaxel (Taxotere)
FDA Link
08/2012
1
Vascular Endothelial Growth Factor D
IBA
01/2012
1
Vascular Endothelial Growth Factor B
IBA
01/2012
1
Vascular Endothelial Growth Factor C
IBA
01/2012
1
Protein Isoforms (Isoforms)
IBA
12/2011
1
fresolimumab
IBA
12/2011
1
Immunoglobulin G (IgG)
IBA
12/2011
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
10/2010
1
Platinum
IBA
10/2010
1
5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamide
IBA
05/2010
1
Superantigens
IBA
04/2009
1
Bacterial Proteins (Bacterial Protein)
IBA
04/2009
1
5-Hydroxytryptophan (5 Hydroxytryptophan)
IBA
09/2008
Therapy/Procedure
5
Therapeutics
11/2018 - 08/2012
2
Drug Therapy (Chemotherapy)
08/2012 - 10/2010
1
Computer-Assisted Surgery (Image Guided Surgery)
09/2020
1
Segmental Mastectomy (Lumpectomy)
09/2020
1
Neoadjuvant Therapy
01/2015
1
Radiotherapy
01/2015
1
Chemoradiotherapy
01/2015
1
Intravenous Administration
07/2013
1
Aftercare (After-Treatment)
06/2013